A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease
- Status
- RECRUITING
- Phase
- NA
A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234
- Status
- COMPLETED
- Phase
- PHASE1
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
PROCARE - PROstate Cancer Real World Evidence Registry
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER
- Status
- COMPLETED
- Phase
- N/A
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)
- Status
- RECRUITING
- Phase
- PHASE2
Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389
- Status
- COMPLETED
- Phase
- PHASE1
Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
- Status
- RECRUITING
- Phase
- NA
A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma
- Status
- COMPLETED
- Phase
- PHASE1
The Anifrolumab PRIM Program
- Status
- RECRUITING
- Phase
- N/A
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2